Known and potential new risk factors for skin cancer in European populations: A multicentre case-control study

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 1-13

  De Vries, E ^a   Trakatelli, M ^b   Kalabalikis, D ^b   Ferrandiz, L ^c   Ruiz De Casas, A ^c   Moreno Ramirez, D ^c   Sotiriadis, D ^b   Ioannides, D ^b   Aquilina, S ^d   Apap, C ^d   Micallef, R ^e   Scerri, L ^d   Ulrich, M ^f   Pitkanen S ^g   Saksela, O ^g   Altsitsiadis, E ^f,h   Hinrichs, B ^f   Magnoni, C ⁱ   Fiorentini, C ⁱ   Majewski, S ^j   Ranki, A ^g   Stockfleth, E ^f   Proby, C ^k   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d Sir Paul Boffa Hospital   (Malta)

^e Sir Paul Boffa Hospital ^*  (Malta)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^j MEDICAL UNIVERSITY OF WARSAW   (Poland)

^k UNIVERSITY OF DUNDEE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; THIAZIDE DIURETIC AGENT; THIAZINE DERIVATIVE;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG USE; DYSPLASTIC NEVUS; FEMALE; FINLAND; GERMANY; GREECE; HUMAN; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALTA; MELANOMA; POLAND; POMEGRANATE; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN CANCER; SKIN PIGMENTATION; SQUAMOUS CELL CARCINOMA; STRESS; SUN EXPOSURE;

EID: 84864983740     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11081.x     Document Type: Article

References (53)

1. Rubin AI, Chen EH, Ratner D,. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-9.
2. Holterhues C, Vries E, Louwman MW, et al. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol 2010; 130: 1807-12.
3. Armstrong BK, Kricker A,. The epidemiology of UV induced skin cancer. J Photochem Photobiol, B 2001; 63: 8-18.
4. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131: 164-9.
5. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131: 157-63.
6. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
7. Lear JT, Tan BB, Smith AG, et al. A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. Int J Clin Pract 1998; 52: 145-9.
8. Lear JT, Tan BB, Smith AG, et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997; 90: 371-4.
9. Diepgen TL, Mahler V,. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl. 61): 1-6.
10. Wolin KY, Carson K, Colditz GA,. Obesity and cancer. Oncologist 2010; 15: 556-65.
11. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.
12. van Hattem S, Aarts MJ, Louwman WJ, et al. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in the Netherlands. Br J Dermatol 2009; 161: 840-5.
13. van der Aa MA, de Vries E, Hoekstra HJ, et al. Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005. Eur J Cancer 2011; 47: 1056-60.
14. de Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001; 19: 231-8.
15. Cowen EW, Nguyen JC, Miller DD, et al. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 2010; 62: 31-7.
16. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-4.
17. Stern RS,. Photocarcinogenicity of drugs. Toxicol Lett 1998; 102-103: 389-92.
18. Sayre RM, Dowdy JC,. The increase in melanoma: are dietary furocoumarins responsible? Med Hypotheses 2008; 70: 855-9.
19. Grossweiner LI,. Mechanisms of photosensitization by furocoumarins. Natl Cancer Inst Monogr 1984; 66: 47-54.
20. Loveday KS,. Interrelationship of photocarcinogenicity, photomutagenicity and phototoxicity. Photochem Photobiol 1996; 63: 369-72.
21. Jensen JD, Wing GJ, Dellavalle RP,. Nutrition and melanoma prevention. Clin Dermatol 2010; 28: 644-9.
22. Smith N, Fuhrmann T, Tausk F,. Psychoneuro-oncology: its time has arrived. Arch Dermatol 2009; 145: 1439-42.
23. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006; 6: 240-8.
24. Chida Y, Hamer M, Wardle J, Steptoe A,. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008; 5: 466-75.
25. Kricker A, Armstrong BK, English DR, Heenan PJ,. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995; 60: 482-8.
26. Bataille V, Boniol M, de Vries E, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005; 41: 2141-9.
27. Sun Y, Huang L, Mackenzie GG, Rigas B,. Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents. J Pharmacol Exp Ther 2011; 338: 775-83.
28. Ramirez CC, Ma F, Federman DG, Kirsner RS,. Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients. Dermatol Surg 2005; 31: 748-52.
29. Marks F, Muller-Decker K, Furstenberger G,. A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 2000; 153: 11-26.
30. Johnsen JI, Lindskog M, Ponthan F, et al. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Cancer Res 2004; 64: 7210-15.
31. Seed MP, Brown JR, Freemantle CN, et al. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res 1997; 57: 1625-9.
32. Elmets CA, Viner JL, Pentland AP, et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010; 102: 1835-44.
33. Jensen AO, Svaerke C, Farkas D, et al. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol (Stockh) 2010; 90: 474-9.
34. Wisgerhof HC, van der Geest LG, de Fijter JW, et al. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol 2011; 35: 105-11.
35. Peroutka R, Schulzova V, Botek P, Hajslov J,. Analysis of furanocoumarins in vegetables (Apiaceae) and citrus fruits (Rutaceae). J Sci Food Agric 2007; 87: 2152-63.
36. Rothman KJ,. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-6.
37. Rosso S, Zanetti R, Pippione M, Sancho-Garnier H,. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res 1998; 8: 573-83.
38. Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94: 743-51.
39. Radespiel-Troger M, Meyer M, Pfahlberg A, et al. Outdoor work and skin cancer incidence: a registry-based study in Bavaria. Int Arch Occup Environ Health 2009; 82: 357-63.
40. Karagas MR, Stukel TA, Umland V, et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol 2007; 127: 2901-3.
41. Placzek M, Eberlein-Konig B, Przybilla B,. Association between actinic keratoses and potentially photosensitizing drugs. N Engl J Med 1999; 341: 1474-5.
42. Jensen AO, Thomsen HF, Engebjerg MC, et al. Use of photosensitizing diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer 2008; 99: 1522-8.
43. Gasparro FP,. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence. Am J Clin Dermatol 2000; 1: 337-48.
44. Zhang X, Jeffs G, Ren X, et al. Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light. DNA Repair (Amst) 2007; 6: 344-54.
45. Li F,. DNA Damage and UVA-induced Oxidation of DNA 6-thioguanine. London: University College London, 2010.
46. Ruiter R, Visser LE, Eijgelsheim M, et al. High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer 2010; 46: 2467-72.
47. Saul AN, Oberyszyn TM, Daugherty C, et al. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 2005; 97: 1760-7.
48. Gibertini M, Reintgen DS, Baile WF,. Psychosocial aspects of melanoma. Ann Plast Surg 1992; 28: 17-21.
49. Parker J, Klein SL, McClintock MK, et al. Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis. J Am Acad Dermatol 2004; 51: 919-22.
50. Hasegawa H, Saiki I,. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 2002; 93: 729-35.
51. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, et al. Distress and DNA repair in human lymphocytes. J Behav Med 1985; 8: 311-20.
52. Yang EV, Glaser R,. Stress-induced immunomodulation: implications for tumorigenesis. Brain Behav Immun 2003; 17 (Suppl. 1): S37-40.
53. de Vries E, Boniol M, Severi G, et al. Public awareness about risk factors could pose problems for case-control studies: the example of sunbed use and cutaneous melanoma. Eur J Cancer 2005; 41: 2150-4.